Abstract
Curcumin (CUR) is a yellow-coloured polyphenolic compound obtained from the rhizomes of Curcuma longa. In-depth pharmacological screening of curcumin has given the evidence that CUR persuades shielding and curative effects against various cancers, cardiovascular, wound healing effect and neuro disorders etc owning to anti-oxidant, antiproliferative, anti-inflammatory, anti-angiogenic and antimicrobial activities. However, miserable bioavailability due to poor aqueous solubility limits the application of CUR in various ailments. Different methodologies including the nanoparticle technology have been reported for the bioavailability enhancement of CUR. Nanoparticles exhibit not only the improvement in the solubility of CUR and alike lipophilic molecules (resulted in improved bioavailability) but also giving the opportunity for the disease specific cellular and organ targeting. Improved bioavailability and disease based site specific delivery of CUR is more likely to bring it as a safe multifunctional medicine.
Keywords: Anticancer, anti-inflammatory, bioavailability, curcumin nanocarriers, curcumin, nanocurcumin, nanoparticles, neuroprotective, solid lipid nanoparticles.
Current Drug Discovery Technologies
Title:Transformation of Curcumin from Food Additive to Multifunctional Medicine: Nanotechnology Bridging the Gap
Volume: 11 Issue: 3
Author(s): Mohammad Zaki Ahmad, Shabib Akhter, Nehal Mohsin, Basel A. Abdel-Wahab, Javed Ahmad, Musarrat Husain Warsi, Mahfoozur Rahman, Neha Mallick and Farhan Jalees Ahmad
Affiliation:
Keywords: Anticancer, anti-inflammatory, bioavailability, curcumin nanocarriers, curcumin, nanocurcumin, nanoparticles, neuroprotective, solid lipid nanoparticles.
Abstract: Curcumin (CUR) is a yellow-coloured polyphenolic compound obtained from the rhizomes of Curcuma longa. In-depth pharmacological screening of curcumin has given the evidence that CUR persuades shielding and curative effects against various cancers, cardiovascular, wound healing effect and neuro disorders etc owning to anti-oxidant, antiproliferative, anti-inflammatory, anti-angiogenic and antimicrobial activities. However, miserable bioavailability due to poor aqueous solubility limits the application of CUR in various ailments. Different methodologies including the nanoparticle technology have been reported for the bioavailability enhancement of CUR. Nanoparticles exhibit not only the improvement in the solubility of CUR and alike lipophilic molecules (resulted in improved bioavailability) but also giving the opportunity for the disease specific cellular and organ targeting. Improved bioavailability and disease based site specific delivery of CUR is more likely to bring it as a safe multifunctional medicine.
Export Options
About this article
Cite this article as:
Ahmad Zaki Mohammad, Akhter Shabib, Mohsin Nehal, Abdel-Wahab A. Basel, Ahmad Javed, Warsi Husain Musarrat, Rahman Mahfoozur, Mallick Neha and Ahmad Jalees Farhan, Transformation of Curcumin from Food Additive to Multifunctional Medicine: Nanotechnology Bridging the Gap, Current Drug Discovery Technologies 2014; 11 (3) . https://dx.doi.org/10.2174/1570163811666140616153436
DOI https://dx.doi.org/10.2174/1570163811666140616153436 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Platelet Ca2+ATPases: Identification and Regulation in Hypertension
Current Hypertension Reviews New Perspectives to Repair a Broken Heart
Cardiovascular & Hematological Agents in Medicinal Chemistry A Role of Thyroid Hormones in Acute Myocardial Infarction: An Update
Current Cardiology Reviews Augmenting Anger Control Therapy with a Videogame Requiring Emotional Control: A Pilot Study on an Inpatient Psychiatric Unit
Adolescent Psychiatry Peroxisome Proliferator-Activated Receptor-α Activation Protects Brain Capillary Endothelial Cells from Oxygen-Glucose Deprivation-Induced Hyperpermeability in the Blood-Brain Barrier
Current Neurovascular Research Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke
CNS & Neurological Disorders - Drug Targets Platelet-Derived Chemokines in Atherogenesis: What’s New?
Current Vascular Pharmacology The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review
Protein & Peptide Letters GABAA Receptor Channel Pharmacology
Current Pharmaceutical Design Role of Hyperglycaemia in Pathogenesis of Diabetic Cardiovascular Disease
Vascular Disease Prevention (Discontinued) Canonical Wnt/Beta-Catenin Signaling Network as Emerging Signaling Cascade for Therapeutic Intervention in Chronic Renal Disease
Current Drug Targets Transdermal Delivery: Product and Patent Update
Recent Patents on Drug Delivery & Formulation Antiplatelet Therapy in Peripheral Arterial Disease
Current Drug Targets - Cardiovascular & Hematological Disorders The Potential Protective Effect of Orange Peel and Selenium against 17β-Estradiol- Induced Chronic Non-Bacterial Prostatitis in Rats
Anti-Cancer Agents in Medicinal Chemistry Significant Association of CXCL12 rs1746048 with LDL-C Level in Intracranial Aneurysms
Current Neurovascular Research Single Molecule Techniques for Biomedicine and Pharmacology
Current Pharmaceutical Biotechnology Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews A New Model for Academics Based Drug Discovery
Current Alzheimer Research Harnessing CD36 to Rein in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Lipoxins, The Novel Mediators of Gastroprotection and Gastric Adaptation to Ulcerogenic action of Aspirin
Current Pharmaceutical Design